ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that its board of directors has approved a Stock Repurchase Program authorizing the repurchase of up to 1,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices through October 31, 2010. The board of directors believes that BRLI’s common stock is currently undervalued and that a Repurchase Program of this nature constitutes an appropriate investment that will benefit BRLI’s stockholders.
